Drugs / Bone Healing Accelerant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06258499 | Mar → Sep 2024 | — | Carmell Therapeutics Corporation | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bone Healing Accelerant | “This study is being conducted to demonstrate the safety and effectiveness of Bone Healing Accelerant (BHA) product when applied to the joint space of the ankle of hindfoot (the...” NCT06258499 ↗ |
| Known as | BHA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06258499 ↗ |
| Route | Other | “It is manually placed into the joint fusion space during fusion surgery.” NCT06258499 ↗ |